SCM
NVO

Symons Capital Management’s Novo Nordisk NVO Stock Holding History

Symons Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-456,854
Closed -$12.2M – 73
2015
Q1 		$12.2M Sell
456,854
-3,300
-0.7% -$76K 2.78% 19
2014
Q4 		$9.74M Sell
460,154
-235,430
-34% -$5.26M 2.31% 25
2014
Q3 		$16.6M Sell
695,584
-17,910
-3% -$412K 3.49% 7
2014
Q2 		$16.5M Sell
713,494
-432,650
-38% -$9.55M 3.67% 8
2014
Q1 		$26.2M Sell
1,146,144
-28,646
-2% -$610K 5.99% 1
2013
Q4 		$21.7M Buy
1,174,790
+586,720
+100% +$10.2M 5.01% 5
2013
Q3 		$9.95M Buy
+588,070
New +$9.89M 2.7% 20

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Symons Capital Management's NVO Position: Q2 2015 in Review

Symons Capital Management sold out of Novo Nordisk (NVO) in Q2 2015, closing a stake of 456,854 shares — an estimated $12.2M sold.

Symons Capital Management first reported a position in NVO in Q3 2013 and held it in 7 quarters. The position peaked at $26.2M in Q1 2014. 516 funds tracked by Wall St. Rank hold NVO as of Q2 2015.

  • Symons Capital Management reported no remaining Novo Nordisk position as of Q2 2015 after selling out during the quarter.
  • Symons Capital Management sold 456,854 Novo Nordisk shares in Q2 2015, an estimated $12.2M.
  • Symons Capital Management first reported a position in Novo Nordisk in Q3 2013 and held it in 7 quarters.
  • Symons Capital Management's Novo Nordisk position peaked at $26.2M in Q1 2014.
  • 516 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2015.

Based on Symons Capital Management's 13F filing for Q2 2015, filed 10 Aug 2015.